Showing results (491-500 of 544) with videos related to
Sort By:
Pageof 55
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer ConsortiumVeronica Wendy Setiawan, Jennifer A Doherty, Xiao-Ou Shu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.Cancer Research|June 25, 2017
Functionally Null <i>RAD51D</i> Missense Mutation Associates Strongly with Ovarian CarcinomaBarbara Rivera, Massimo Di Iorio, Jessica Frankum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.International Journal of Epidemiology|June 19, 2019
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization studyHolly R Harris, Kara L Cushing-Haugen, Penelope M Webb, et al.American Journal of Epidemiology|December 13, 2016
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control StudiesChristina B Rasmussen, Susanne K Kjaer, Vanna Albieri, et al.The Prostate|January 22, 2013
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in PolandWojciech Kluźniak, Dominika Wokołorczyk, Aniruddh Kashyap, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.Pageof 55